参考文献/References:
[1] Chamot AM, Benhamou CL, Kahn MF, et al. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a National survey. 85 cases[J]. Rev Rhum Mal Osteoartic, 1987, 54(3):187-196.
[2] Boutin RD, Resnick D. The SAPHO syndrome:an evolving concept for unifying several idiopathic disorders of bone and skin[J]. AJR Am J Roentgenol, 1998, 170(3):585-591.
[3] Salles M, Olive A, Perez-Andres RA, et al. The SAPHO syndrome:a clinical and imaging study[J]. Clin Rheumatol, 2011, 30(2):245-249.
[4] Pichler R, Weiglein K, Schmekal B, et al. Bone scintigraphy using Tc-99m DPD and F18-FDG in a patient with SAPHO syndrome[J]. Scand J Rheumatol, 2003, 32(1):58-60.
[5] Kohlfuerst S, Igerc I, Lind P. FDG PET helpful for diagnosing SAPHO syndrome[J]. Clin Nucl Med, 2003, 28(10):838-839.
[6] Inoue K, Yamaguchi T, Ozawa H, et al. Diagnosing active inflammation in the SAPHO syndrome using 18FDG-PET/CT in suspected metastatic vertebral bone tumors[J]. Ann Nucl Med, 2007, 21(8):477-480.
[7] Takeuchi K, Matsusita M, Takagishi K. A case of SAPHO(synovitis-acne-pustulosis-hyperostosis-osteomyelitis) syndrome in which[18F] fluorodeoxyglucose positron emission tomography was useful for differentiating from multiple metastatic bone tumors[J]. Mod Rheumatol, 2007, 17(1):67-71.
[8] Patel CN, Smith JT, Rankine JJ, et al. F-18 FDG PET/CT can help differentiate SAPHO syndrome from suspected metastatic bone disease[J]. Clin Nucl Med, 2009, 34(4):254-257.
[9] Abuhid IM, Silva LC, Martins GP, et al. Diagnosing SAPHO syndrome in suspected metastatic bone tumors[J]. Clin Nucl Med, 2010, 35(3):172-174.
[10] Kahn MF. Psoriatic arthritis and synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome[J]. Curr Opin Rheumatol, 1993, 5(4):428-435.
[11] Colina M, Govoni M, Orzincolo C, et al. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome:a single center study of a cohort of 71 subjects[J]. Arthritis Rheum, 2009, 61(6):813-821.
[12] Ferguson PJ, Bing X, Vasef MA, et al. A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis[J]. Bone, 2006, 38(1):41-47.
[13] Tlougan BE, Podjasek JO, O’haver J, et al. Chronic recurrent multifocal osteomyelitis(CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis(SAPHO)syndrome with associated neutrophilic dermatoses:a report of seven cases and review of the literature[J]. Pediatr Dermatol, 2009, 26(5):497-505.
[14] Earwaker JW, Cotten AS. SAPHO:Syndrome or concept? Imaging findings[J]. Skeletal Radiol, 2003, 32(6):311-327.
[15] Witt M, Meier J, Hammitzsch A, et al. Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany:results from a nationwide patient survey[J]. Semin Arthritis Rheum, 2014, 43(6):745-750.
[16] Cotten A, Flipo RM, Mentre A, et al. SAPHO syndrome[J]. RadioGraphics, 1995, 15(5):1147-1154.
[17] Mann B, Shaerf DA, Sheeraz A, et al. SAPHO syndrome presenting as widespread bony metastatic disease of unknown origin[J]. Rheumatol Int, 2012, 32(2):505-507.
[18] Aljuhani F, Tournadre A, Tatar Z, et al. The SAPHO syndrome:a single-center study of 41 adult patients[J]. J Rheumatol, 2015, 42(2):329-334.
[19] Maugars Y, Berthelot JM, Ducloux JM, et al. SAPHO syndrome:a followup study of 19 cases with special emphasis on enthesis involvement[J]. J Rheumatol, 1995, 22(11):2135-2141.
[20] Reith JD, Bauer TW, Schils JP. Osseous manifestations of SAPHO(synovitis, acne, pustulosis, hyperostosis, osteitis)syndrome[J]. Am J Surg Pathol, 1996, 20(11):1368-1377.
[21] Laredo JD, Vuillemin-Bodaghi V, Boutry N, et al. SAPHO syndrome:MR appearance of vertebral involvement[J]. Radiology, 2007, 242(3):825-831.
[22] Depasquale R, Kumar N, Lalam RK, et al. SAPHO:what radiologists should know[J]. Clin Radiol, 2012, 67(3):195-206.
相似文献/References:
[1]任越,张慧芳,胡波,等.电离辐射诱导小鼠骨电子顺磁共振信号检测的影响因素[J].国际放射医学核医学杂志,2015,39(5):371.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 004]
ren yue,zhang huifang,hu bo,et al.influencing factors of detection on ionizing radiation-induced electron paramagnetic resonance signal in bones[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):371.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 004]
[2]张胤,陈跃.18F-氟化钠PET/CT诊断肿瘤骨转移应用进展[J].国际放射医学核医学杂志,2015,39(1):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
Zhang Yin,Chen Yue.Application progress of 18F-NaF PET/CT in the diagnosis of neoplasm metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
[3]白剑强,夏群,胡永成.放射性核素骨显像在脊柱转移瘤诊断中的价值[J].国际放射医学核医学杂志,2011,35(1):28.[doi:10.3760/cma.j.issn.1673-4114.2011.01.008]
BAI Jian-qiang,XIA Qun,HU Yong-cheng.Evaluate the diagnostic value of radionuclide bone imaging of metastatic spine tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):28.[doi:10.3760/cma.j.issn.1673-4114.2011.01.008]
[4]徐海青,段俊,吴边.全身骨显像诊断前列腺癌骨转移与PSA水平及病理分级的相关性研究[J].国际放射医学核医学杂志,2011,35(1):34.[doi:10.3760/cma.j.issn.1673-4114.2011.01.010]
XU Hai-qing,DUAN Jun,WU Bian.Study of relationship between the bone imaging, level of PSA and pathology grade in diagnosis of prostate carcinoma bone metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):34.[doi:10.3760/cma.j.issn.1673-4114.2011.01.010]
[5]陶欣慰,黄钢.18F-FDGPET与99Tcm-MDP骨显像在诊断肿瘤骨转移中的比较[J].国际放射医学核医学杂志,2010,34(6):352.[doi:10.3760/cma.j.issn.1673-4114,2010.06.008]
TAO Xin-wei,HUANG Gang.Comparasion of 18F-FDG PET and 99Tcm-MDP bone imaging in diagnosis of bone metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(6):352.[doi:10.3760/cma.j.issn.1673-4114,2010.06.008]
[6]段钰,邓小虎,赵增鹏,等.左股骨朗格汉斯细胞组织细胞增生症PET/CT显像一例[J].国际放射医学核医学杂志,2017,41(6):452.[doi:10.3760/cma.j.issn.1673-4114.2017.06.013]
[7]王志军,丛英珍,高燕飞,等.SPECT/CT骨显像对SAPHO综合征的诊断价值[J].国际放射医学核医学杂志,2018,(4):321.[doi:10.3760/cma.j.issn.1673-4114.2018.04.006]
Wang Zhijun,Cong Yingzhen,Gao Yanfei,et al.Value of SPECT/CT bone imaging in the diagnosis of SAPHO syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(6):321.[doi:10.3760/cma.j.issn.1673-4114.2018.04.006]